Optic Atrophy, Autosomal Dominant
Showing 1 - 25 of 3,028
Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation
Not yet recruiting
- Autosomal Dominant Optic Atrophy
- +3 more
-
Sydney, AustraliaSydney Eye Hospital
Nov 15, 2023
Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney
Recruiting
- Rare Disorders
- +309 more
-
Sioux Falls, South Dakota
- +1 more
Jun 20, 2022
Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay Trial in Saguenay (Rehabilitation)
Recruiting
- Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay
- Rehabilitation
-
Saguenay, Quebec, CanadaGroupe de recherche interdisciplinaire sur les maladies neuromus
Mar 3, 2023
Spastic Ataxia Trial in Worldwide (Clinical rating scale to measure Ataxia disease severity and progression, Clinical rating
Recruiting
- Spastic Ataxia
- Clinical rating scale to measure Ataxia disease severity and progression
- +3 more
-
Montreal,, Quebec, Canada
- +8 more
May 17, 2022
Cerebral Autosomal Dominant Arteriopathy With Subcortical
Recruiting
- CADASIL
- Study Procedures
-
Los Angeles, California
- +11 more
Jan 24, 2023
Alzheimer's Disease Trial in Colombia (Crenezumab, Placebo)
Active, not recruiting
- Alzheimer's Disease
- Crenezumab
- Placebo
-
Armenia, Colombia
- +3 more
Nov 21, 2022
Retinal Disease, Age-Related Macular Degeneration, Retinitis Pigmentosa Trial in Westport, Coral Springs, Dubai (Arm 1)
Recruiting
- Retinal Disease
- +17 more
- Arm 1
-
Westport, Connecticut
- +2 more
Nov 25, 2022
CLARIFY: ADH1 and ADH2 Disease Monitoring Study (DMS)
Recruiting
- Autosomal Dominant Hypocalcemia
-
Indianapolis, Indiana
- +14 more
Dec 6, 2022
The Polycystic Liver Disease Questionnaire (PLD-Q).
Recruiting
- Polycystic Liver Disease
- PLD-Q
-
Rochester, MinnesotaMayo Clinic
Nov 15, 2022
A Prospective Observational Study of Foam Sclerotherapy .
Recruiting
- Autosomal Dominant Polycystic Kidney
- +3 more
-
Rochester, MinnesotaMayo Clinic
Jul 11, 2022
AusCADASIL: An Australian Cohort of CADASIL
Recruiting
- Cadasil
-
Newcastle, New South Wales, Australia
- +4 more
Nov 18, 2023
Autosomal Dominant Hypocalcemia (ADH) Trial in Greenville (Encaleret, Calcium supplements and active Vitamin D (calcitriol,
Recruiting
- Autosomal Dominant Hypocalcemia (ADH)
- Encaleret
- Calcium supplements and active Vitamin D (calcitriol, alfacalcidol, falecalcitriol, etc.)
-
Greenville, North CarolinaPhysicians East
Jan 9, 2023
Identification of Dominant Calpainopathies
Enrolling by invitation
- Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A
- retrospective study
-
Venice-Lido, VE, Italy
- +1 more
Jul 19, 2023
Eardream Data Collection in Colombia Supported by ADDF
Recruiting
- Alzheimer Disease, Early Onset
- This is an observational study
-
Medellín, ColombiaFundacion Universitaria de Antioquia
Oct 5, 2022
Genetic Testing in Autosomal Dominant Polycystic Kidney Disease
Recruiting
- ADPKD
- Survey
-
San Francisco, CaliforniaUCSF
Oct 18, 2023
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Recruiting
- Autosomal Dominant Polycystic Kidney Disease
-
Rochester, MinnesotaMayo Clinic in Rochester
Aug 15, 2022
Autosomal Dominant Hypocalcemia (ADH) Trial run by the (CLTX-305)
Active, not recruiting
- Autosomal Dominant Hypocalcemia (ADH)
-
Bethesda, MarylandNational Institute of Health
Jul 20, 2022
Identification of Acute Intermittent Porphyria Modifying Genes
Not yet recruiting
- Acute Intermittent Porphyria (AIP)
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Aug 12, 2022
Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study
Recruiting
- ADPKD
-
Washington, District of ColumbiaChildren's National Hospital
Aug 26, 2022
Autosomal Dominant Polycystic Kidney Disease Trial in Rochester
Recruiting
- Autosomal Dominant Polycystic Kidney Disease
-
Rochester, MinnesotaMayo Clinic
Aug 15, 2022
Intrarenal Microvasculature in ADPKD
Recruiting
- Autosomal Dominant Polycystic Kidney Disease
-
Rochester, MinnesotaMayo Clinic
Aug 15, 2022
ADPKD Trial (Ketone ester)
Not yet recruiting
- ADPKD
- Ketone ester
- (no location specified)
Oct 20, 2023
Optic Pathway Glioma Trial in Rome (CHF6467, Placebo)
Not yet recruiting
- Optic Pathway Glioma
- CHF6467
- Placebo
-
Rome, ItalyCatholic University, Policlinico A. Gemelli (Hospital)
Feb 17, 2023